Dr. Brewington is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3333 Burnet Ave
# ML2021
Cincinnati, OH 45229Phone+1 513-636-6771Fax+1 513-636-4615
Summary
- Dr. John Brewington is a Pediatric Pulmonologist based in Cincinnati, Ohio. He completed his residency, chief residency, and fellowship at Cincinnati Children's Hospital Medical Center after graduating from Wake Forest School of Medicine. Dr. Brewington is a physician-scientist focused on research in cystic fibrosis, specifically studying novel methods to support personalized care and precision medicine. He has had continuous funding from the CFF and NIH since 2018 and directs the CFF National Resource Center for nasal cell-based theratyping. Clinically, Dr. Brewington focuses on the care of patients with airway disorders, including congenital airway abnormalities, cystic fibrosis, and technology-dependent patients. He is dedicated to medical education, and is the co-director of the annual international Pediatric Flexible Bronchoscopy Course in Cincinnati.
Education & Training
- Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Pulmonology, 2013 - 2016
- Cincinnati Children's Hospital Medical CenterChief Residency, Pediatrics, 2012 - 2013
- Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 2009 - 2012
- Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2009
Certifications & Licensure
- OH State Medical License 2012 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Pulmonology
Clinical Trials
- Testing Drug Efficacy in Cystic Fibrosis Through N-of-1 Trials Start of enrollment: 2021 May 01
Roles: Contact
Publications & Presentations
PubMed
- 17 citationsWhen CFSPID becomes CF.Daniella Ginsburg, Choo Phei Wee, Maria Carmen Reyes, John J. Brewington, Danieli Salinas
Journal of Cystic Fibrosis. 2021-10-28 - 15 citationsGradual increase in sweat chloride concentration is associated with a higher risk of CRMS/CFSPID to CF reclassification.Danieli B Salinas, Daniella K Ginsburg, Choo Phei Wee, Muhammed M Saeed, John J Brewington
Pediatric Pulmonology. 2023-04-01 - 42 citationsNeutrophil extracellular traps activate IL-8 and IL-1 expression in human bronchial epithelia.Kristin M. Hudock, Margaret S. Collins, Michelle Imbrogno, John Snowball, Elizabeth L. Kramer
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2020-03-11
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: